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Detection of $O]KHLPHU¶VGLVHDVH$'in routine neurological management of middle-aged/elderly 
adults is challenging.  Standard assessments of episodic memory and brain atrophy are useful to 
detect the prodromal mild cognitive impairment stage of AD but fail to identify the earliest 
preclinical cases.  Longitudinal research has indicated that at this earliest stage of AD there is a 
subtle decline of semantic memory.  A focus on latent and more qualitative aspects of semantic 
performance (which transcend the simple raw quantitative score) might be a better biomarker of 
preclinical AD. Sticking to episodic memory may be effective to diagnose prodromal disease, but 
does not offer many opportunities for clinical research to progress towards cognitive biomarkers of 
earlier application. 
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Uncovering WKHSUHVHQFHRI$O]KHLPHU¶VGLVHDVH$'in routine neurological management of 
middle-aged/elderly adults, and differentiating its combination of symptoms from those induced by 
the processes of normal ageing, neurovascular disease, or psychiatric conditions (e.g. depression), 
are challenges of primary importance.  Usually, it is the onset of behavioural symptoms that 
encourages patients with AD and caregivers to seek medical attention for the first time.  Research 
evidence, however, shows that the earliest changes triggered by the disease on the biology of the 
brain occur several decades prior to any behavioural change of clinical relevance [1].  Based on this 
large preclinical-stage/symptomatic-stage temporal discrepancy, it is of paramount importance to 
identify biomarkers that are more effective than those currently used in clinical practice.  Alongside 
maximised levels of sensitivity and specificity, an ideal biomarker should be of as early diagnostic 
avail as possible along the disease-progression timeline.  On this note, the use of cognitive tests is 
among the most proficient sources of clinical information in the early phases of AD, due to their 
validity, reliability, and simplicity/immediateness.  A skilful interpretation of neuropsychological 
performance may offer an indirect, yet fruitful view of the pathological processes affecting the 
nervous system, which could be the result of incipient AD. 
Although episodic memory impairment has been classically recognised as the main symptom of the 
prodromal AD stage characterised by mild cognitive impairment (MCI) [2], a temporally parallel 
decline of semantic memory has also been described [3, 4].  The basic clinical disadvantage 
associated with episodic memory is that a qualitatively (but certainly not quantitatively) similar 
memory GHFOLQHLVDOVR³SK\VLRORJLFDOO\´YLVLEOH in the absence of any pathologies in the general 
population of elderly adults.  In contrast, semantic memory remains fairly stable across the lifespan, 
and aspects of lexical-semantic abilities even appear to improve with age [5].  Based on this, using 
the same logic argument that sustains all differential diagnoses, measuring semantic memory can be 
discriminative in separating healthy and pathological ageing. 
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Nevertheless, the most recent criteria for the detection of the earliest clinical manifestation of AD [6, 
7] persist in highlighting the sole role of measures of episodic retrieval.  A major reason behind the 
choice of episodic memory as the cognitive sub-GRPDLQ³RIUHIHUHQFH´OLHVLQWKHIDFWWKDW
prodromal, early-symptomatic AD (manifesting in the form of MCI) corresponds to the 
pathophysiological moment in which the neurofibrillary pathology intensifies within the 
hippocampal complex [8].  This mediotemporal structure sustains the neocortical circuitry 
responsible for context-associated, episodic memory [9].  Based on this, the theoretical convergence 
of peptidic accumulation of hypephosphorilated TAU protein within hippocampal cells, 
macrostructural volumetric loss of this same structure, and impaired performance in tests assessing 
episodic retrieval would represents a multi-domain ensemble which (as soon as TAU imaging is 
made routinely available) will be extremely powerful in the clinical setting for a diagnosis of 
symptomatic, probable AD.  This diagnostic formula is meant to capture a very specific snapshot of 
the disease, which is bound to the %UDDNDQG%UDDN¶Vlimbic stages of AD, and which, simply, ³GRHV
QRWQHHG´ to investigate semantic memory.  This, however, does not mean that patients with MCI do 
not manifest any semantic decline.  Converging evidence shows, in fact, that these patients suffer 
from semantic impairment across multiple domains: naming, category verbal fluency, spontaneous 
speech, knowledge about famous people, historical facts, famous public events, and even cultural 
knowledge [3]. 
On the quest for an accurate biomarker, it is fair to acknowledge that there might be alternative and 
more adequate diagnostic routes than that centered on the combination of episodic memory 
impairment-hippocampal atrophy.  Multiple theoretical models indicate that the clinical moment in 
which objective cognitive impairment is seen and a diagnosis is reached, is preceded by a rather 
long phase of preclinical changes.  During this period, the cerebrospinal levels of TAU and E 
Amyloid protein are dysregulated [1] and neurofibrillary tangles start depositing on the basal, 
transentorhinal portion of the mediotemporal complex, including the perirhinal and entorhinal 
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cortices [8].  Interestingly, these two subcomponents are part of mediotemporal networks which 
FRQQHFWWRDUHDVRIWKHDVVRFLDWLYHFRUWH[PDLQO\UHVSRQVLEOHIRU³FRQWH[W-IUHH´UHWULHYDOSURFHVVHV
(out of which semantic memory represents a major example), and are anatomically distinct from the 
mediotemporal-neocortical circuitry of the other aforementioned subcomponent based on 
hippocampal and parahippocampal gyri [9].  According to this view, the distribution of Braak Stage I 
lesions would induce functional disconnection within the transentorhinal, mediotemporal network 
responsible for semantic but not for episodic declarative memory.  In fact, Stage I spares the 
hippocampus, which remains free of Alzheimer pathology.  This indicates that differences in 
measures of semantic memory must be visible between healthy adults and future patients 
undergoing Braak Stage I.  Using the neuropsychological instruments at clinical disposal, however, 
individuals in this asymptomatic or minimally-symptomatic phase result undistinguishable from 
healthy adults. 
Cognitive tests have been mainly designed to classify performance as falling within normality, in a 
borderline ³JUH\´area, or below cut-off.  These instruments are not sufficiently fine-grained to 
quantify in detail the extent to which a cognitive function is down-regulated by the preclinical 
mechanisms of neurodegeneration.  Furthermore, other factors such as, for example, cognitive 
reserve might mask/compensate for the effect of neurodegeneration [10].  Under normal conditions, 
common testing instruments such as the raw score on the Category Fluency test or on the 
³Similarities´ WAIS subtest are not sufficiently helpful to characterise performance of people at the 
preclinical stage of the disease.  Moreover, to further complicate the picture, no test taps only one 
subtype of declarative memory or is, in terms of neural correlates, exclusively related to a sole brain 
network.  As for the aforementioned mediotemporal-neocortical circuitry, evidence indicates that 
semantic retrieval in adults with MCI is associated with an involvement of perirhinal/entorhinal 
areas, as expected, but also with anterior hippocampal regions [3].  In all likelihood, recall from the 
semantic storage is open to concurrent processing of episodic (e.g. autobiographical) nature.  
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Conversely, any meaningful episodic retrieval entails some degree of reliance on lexical-semantic 
material.  In fact, tests like the Rey Auditory Verbal Learning Test or the Prose Memory Test are 
profoundly dependent on lexical-semantic processes. 
A series of investigations, however, have demonstrated that other latent and more qualitative 
aspects of semantic performance (which transcend the simple raw quantitative score) are 
informative and of potential clinical utility for the characterisation of the earliest stages of the 
disease [11].  Individuals who are still asymptomatic but are destined to develop a hereditary form of 
AD due to a mutation of the Presenilin-1 gene, for instance, were found to score significantly lower 
than healthy controls in a series of tasks assessing semantic fluency, naming of famous people, and 
word definition [12].  Longitudinal evidence comes instead from a set of fascinating studies which 
investigated in a retrospective and detailed fashion the preclinical morphological-syntactical and 
lexical-semantic skills of adults, as a function of their future conversion to clinically-established 
AD.  A well-acknowledged study is that authored by Snowdon and collaborators [13], carried out on 
a group of nuns who had written autobiographical diaries in their early adulthood (i.e. more than 50 
years prior to neuropathological assessment carried out to confirm/rule out a diagnosis of AD).  The 
findings indicated that the nuns with confirmed diagnosis of AD had lower levels of idea density in 
their early twenties.  Moreover, lower levels of idea density and syntactical complexity were 
associated with lower cognitive scores at follow up.  Along the same line, a single-case study 
examined in a detailed and unique way the literary performance of the famous British writer Iris 
Murdoch throughout her career, up until the last book plausibly written during the preclinical phase 
of AD.  Results indicated that her later opuses were characterised by a more limited vocabulary and 
by the use of more high-frequency words [14].  Additional analyses on her life long literary 
productions showed that impoverished vocabulary and syntax were already present in her writings 
from her late 40s and 50s, decades before the clinical onset of AD [15].  A similarly semantic, but 
somehow even more abstract mechanism, was recently reported in the longitudinal characterisation 
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of the painting skills of a Chinese painter, who showed a progressive impoverishment in his work, 
concurrent with the progression of AD [16].  These studies are accompanied by other research that 
has looked at latent aspects of lexical performance in the spectrum from normal ageing to MCI and 
AD [17, 18].  This latter research has shown that older adults outperformed people with clinical AD, 
its prodromal MCI stage and also young controls in category fluency, producing more words which 
are later acquired, less typical and less familiar [18]. Furthermore, other evidence suggests that these 
same parameters can differentiate MCI carriers of the APOE H4 mutation who are at increased 
genetic risk of progression to AD from those who are more genetically protected [19]. Alterations of 
semantic memory can also be revealed in the preclinical phase of AD using object naming [20] or 
naming of famous faces.  An area of semantic memory that also appears to be especially affected is 
the naming of famous faces (NFF), with some evidence indicating that NFF is one of the best tasks 
to identify people who might develop future AD [20]. 
These studies clearly do not represent a body of evidence sufficiently robust to discDUGWKH³FODVVLF´
diagnostic paradigm centered on episodic memory and embrace a qualitative analysis of semantic 
memory as the core clinical aspect.  Multidimensional evidence, however, indicates that tracking 
the decline in semantic memory may help 1) separate the effects of non-pathological ageing from 
neurodegeneration more clearly, and 2) measure those aspects of lexical-semantic processing which 
are susceptible to AD even when the disease is in its preclinical asymptomatic stages.  This would 
reflect the clinical moment in which transentorhinal but not hippocampal regions are primarily 
affected by AD pathology in the initial preclinical stages. 
In conclusion, we suggest that research should focus more on the role of mechanisms of semantic 
memory in prodromal and, above all, preclinical AD.  Sticking to episodic memory may be 
effective to diagnose prodromal disease, but does not offer many opportunities for clinical research 
to progress towards cognitive biomarkers of earlier application. 
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